Analyst upgrades: NOC, PFWD and CLS
Posted Apr 25th 2008 11:11AM by Eric Buscemi
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Wal-Mart (WMT), Wendy's Intl (WEN), Northrop Grumman (NOC)
.gif)
MOST NOTEWORTHY: Northrop Grumman, Phase Forward and Celestica were today's noteworthy upgrades:
- Cowen upgraded Northrop Grumman (NYSE: NOC) to Outperform from Neutral following the Q1 report based on accelerating growth. Shares were also upgraded at JP Morgan to Overweight from Neutral.
- Friedman Billings upgraded Phase Forward (NASDAQ: PFWD) to Outperform from Market Perform following the solid Q1 report and views guidance as beatable.
- CIBC raised Celestica (NYSE: CLS) to Sector Outperformer from Sector Performer following Q1 results, citing end markets that look stable.
OTHER UPGRADES:
- JP Morgan upgraded the Consumer Discretionary Sector to Overweight from Underweight.
- Wendy's (NYSE: WEN) was raised to Neutral from Sell at Goldman.
- Progenics Pharmaceuticals (NASDAQ: PGNX) was upgraded at Citigroup to Hold from Sell.
- Merrill Lynch raised Wal-Mart (NYSE: WMT) to Buy from Neutral.
Tags: analyst, celestica, cls, noc, northrop grumman, NorthropGrumman, pfwd, pgnx, phase forward, PhaseForward, progenics, upgrade, wal-mart, wen, wendys, wmt
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
